Shenzhen Maisi Robotics Technology has completed a new strategic financing round of nearly RMB 100 million, with CSC Financial, a “state-backed” institution, as investor, 36Kr reported. The round accelerates product iteration and the rollout of frontier directions such as brain-computer interfaces, and extends coverage to the “last mile” of rehab from hospital to community to home.
The company had already won backing from top investors. Lenovo Capital and Incubator Group backed it for four consecutive rounds, joined by Taiyou Fund, Sihuan Pharmaceutical, Xingchen Fund, Dening Industrial and Shangshan Capital.
Per its website, Maisi was founded in 2016 by a team of returned PhDs and supplies medical and elderly-care exoskeleton robots. Its new CEO Chen Kangning previously worked at multinationals including Johnson and Johnson and brings experience across product registration, channel building and scale-up.
Since inception Maisi has focused on flexible-actuator human-machine interaction, building a product matrix that spans the H-series, A-series, C-series paediatric lower-limb rehab line, the “3000 Steps” wellness range and the daily-assist MAX range, covering in-hospital rehab, home care and daily mobility.
The “3000 Steps” wellness line breaks the limit of single-scene, site-bound walking with lightweight, portable, human-centred design, fitting hospitals, communities, parks and homes to help users build a habit of 3,000 brisk steps a day.
The company holds more than 200 patents. Core products have NMPA Class II medical-device certification and are in volume production.
In 2025 Maisi’s revenue grew nearly 200 per cent, with overseas markets contributing more than a third.
The sector is heating up. IDC data shows China’s exoskeleton market exceeded RMB 1.6 billion in 2025 with about 26,000 units shipped; medical rehab led in value while consumer-assist drove over 70 per cent of shipments. In 2026 the climb accelerated: Ministry of Commerce data shows domestic smart-exoskeleton demand up 458.4 per cent year on year in the first half, and JD retail data shows transaction volume up over 15,000 per cent year on year.
Policy adds a tailwind. The National Healthcare Security Administration’s 15th Five-Year plan for universal coverage explicitly promotes smart exoskeletons in long-term care. Stacked policy, market and consumer dividends are pulling exoskeletons from niche tech toward a rehab necessity, and the race is now about who ships first at scale.
Editor’s note: This is an adapted translation of the original OFweek Robot report. It has been trimmed and restructured for readability for an international business audience.